Article info
PDFA difficult case
Cryopyrin-associated periodic syndrome: a treatable genetic inflammatory condition
- Correspondence to Dr Dean L Jones, Department of Neurology, Royal Hobart Hospital, Hobart, TAS 7000, Australia; dean.jones{at}utas.edu.au
Citation
Cryopyrin-associated periodic syndrome: a treatable genetic inflammatory condition
Publication history
- Accepted May 3, 2021
- First published June 10, 2021.
Online issue publication
September 17, 2021
Article Versions
- Previous version (10 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Visual loss with chronic meningeal and systemic inflammation
- Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)
- Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features
- MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes
- The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
- Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6–10 November 2005
- A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference
- Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
- Cutaneous signs and mechanisms of inflammasomopathies
- Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry